Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Antiretroviral Drugs
Marketing
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Biktarvy's TAF component has historically been associated with weight gain.
Angus Liu
Jul 23, 2024 4:00am
WHO flags increasing resistance to GSK's Tivicay in 4 countries
Mar 6, 2024 2:02pm
GSK sees £7B in HIV sales by 2026, updates next-gen timelines
Sep 28, 2023 9:00am
Gilead's twice-yearly HIV med snags first nod after FDA rebuff
Aug 22, 2022 10:25am
Gilead trumpets a Biktarvy win in HIV, hepatitis B co-infection
Aug 1, 2022 10:17am
